257 related articles for article (PubMed ID: 37495073)
21. Long-term safety of Ixekizumab in adults with psoriasis, psoriatic arthritis, or axial spondyloarthritis: a post-hoc analysis of final safety data from 25 randomized clinical trials.
Deodhar A; Blauvelt A; Lebwohl M; Feely M; Kronbergs A; Eberhart N; Zhu D; Inman E; Grace E; Holzkaemper T; Rahman P; Marzo-Ortega H; Papp KA; Merola JF; Gottlieb AB; Schwartzman S
Arthritis Res Ther; 2024 Feb; 26(1):49. PubMed ID: 38347650
[TBL] [Abstract][Full Text] [Related]
22. No Significant Effects of IL-23 on Initiating and Perpetuating the Axial Spondyloarthritis: The Reasons for the Failure of IL-23 Inhibitors.
Zhang H; Jiang HL; Dai SM
Front Immunol; 2022; 13():818413. PubMed ID: 35222393
[TBL] [Abstract][Full Text] [Related]
23. Emerging Immunomodulatory Therapies and New Treatment Paradigms for Axial Spondyloarthritis.
Mease P
Curr Rheumatol Rep; 2019 Jun; 21(7):35. PubMed ID: 31172311
[TBL] [Abstract][Full Text] [Related]
24. Back pain in psoriatic arthritis: defining prevalence, characteristics and performance of inflammatory back pain criteria in psoriatic arthritis.
Yap KS; Ye JY; Li S; Gladman DD; Chandran V
Ann Rheum Dis; 2018 Nov; 77(11):1573-1577. PubMed ID: 30077991
[TBL] [Abstract][Full Text] [Related]
25. Emerging therapies for the treatment of spondyloarthritides with focus on axial spondyloarthritis.
Braun J; Kiltz U; Baraliakos X
Expert Opin Biol Ther; 2023 Feb; 23(2):195-206. PubMed ID: 36511882
[TBL] [Abstract][Full Text] [Related]
26. Undifferentiated spondyloarthritis vs ankylosing spondylitis and psoriatic arthritis: a real-life prospective cohort study of clinical presentation and response to treatment.
Paramarta JE; De Rycke L; Ambarus CA; Tak PP; Baeten D
Rheumatology (Oxford); 2013 Oct; 52(10):1873-8. PubMed ID: 23861532
[TBL] [Abstract][Full Text] [Related]
27. IL-23 and axial disease: do they come together?
Mease P; van den Bosch F
Rheumatology (Oxford); 2021 Oct; 60(Suppl 4):iv28-iv33. PubMed ID: 34668015
[TBL] [Abstract][Full Text] [Related]
28. Correspondence on 'No efficacy of anti-IL-23 therapy for axial spondyloarthritis in randomised controlled trials but in post-hoc analyses of psoriatic arthritis-related 'physician-reported spondylitis'?'.
Siebert S; Marzo-Ortega H
Ann Rheum Dis; 2023 Aug; 82(8):e185. PubMed ID: 34844925
[No Abstract] [Full Text] [Related]
29. Axial Disease in Psoriatic arthritis: The presence and progression of unilateral grade 2 sacroiliitis in a psoriatic arthritis cohort.
Feld J; Ye JY; Chandran V; Inman RD; Haroon N; Cook R; Gladman DD
Semin Arthritis Rheum; 2021 Apr; 51(2):464-468. PubMed ID: 33774593
[TBL] [Abstract][Full Text] [Related]
30. Specific descriptions of axial involvement are associated with radiographic damage development after 2 years in psoriatic arthritis patients.
de Hooge M; Ischenko A; Steinfeld S; Nzeusseu A; Elewaut D; Lories R; Van den Bosch F; De Vlam K
Ann Rheum Dis; 2024 Jan; 83(2):194-198. PubMed ID: 37918893
[TBL] [Abstract][Full Text] [Related]
31. Is axial psoriatic arthritis distinct from ankylosing spondylitis with and without concomitant psoriasis?
Feld J; Ye JY; Chandran V; Inman RD; Haroon N; Cook R; Gladman DD
Rheumatology (Oxford); 2020 Jun; 59(6):1340-1346. PubMed ID: 31593590
[TBL] [Abstract][Full Text] [Related]
32. Axial spondyloarthritis and axial psoriatic arthritis: similar or different disease spectrum?
Benavent D; Plasencia-Rodríguez C; Franco-Gómez K; Nieto R; Monjo-Henry I; Peiteado D; Balsa A; Navarro-Compán V
Ther Adv Musculoskelet Dis; 2020; 12():1759720X20971889. PubMed ID: 33240404
[TBL] [Abstract][Full Text] [Related]
33. Non-steroidal anti-inflammatory drugs (NSAIDs) for axial spondyloarthritis (ankylosing spondylitis and non-radiographic axial spondyloarthritis).
Kroon FP; van der Burg LR; Ramiro S; Landewé RB; Buchbinder R; Falzon L; van der Heijde D
Cochrane Database Syst Rev; 2015 Jul; 2015(7):CD010952. PubMed ID: 26186173
[TBL] [Abstract][Full Text] [Related]
34. The 2023 pipeline of disease-modifying antirheumatic drugs (DMARDs) in clinical development for spondyloarthritis (including psoriatic arthritis): a systematic review of trials.
Denis A; Sztejkowski C; Arnaud L; Becker G; Felten R
RMD Open; 2023 Jul; 9(3):. PubMed ID: 37507210
[TBL] [Abstract][Full Text] [Related]
35. Axial involvement in psoriatic arthritis: An update for rheumatologists.
Poddubnyy D; Jadon DR; Van den Bosch F; Mease PJ; Gladman DD
Semin Arthritis Rheum; 2021 Aug; 51(4):880-887. PubMed ID: 34198146
[TBL] [Abstract][Full Text] [Related]
36. Correspondence on 'No efficacy of anti-IL-23 therapy for axial spondyloarthritis in randomised controlled trials but in post-hoc analyses of psoriatic arthritis-related 'physician-reported spondylitis'?'.
Gladman DD; Mease PJ; Bird P; Soriano ER; Chakravarty SD; Shawi M; Lavie F; Gong C; Leibowitz E; Poddubnyy D; Tam LS; Helliwell PS; Kavanaugh A; Deodhar AA; Østergaard M; Baraliakos X
Ann Rheum Dis; 2023 Aug; 82(8):e187. PubMed ID: 35487679
[No Abstract] [Full Text] [Related]
37. Assessing rheumatologists' attitudes and utilization of classification criteria for ankylosing spondylitis and axial spondyloarthritis: a global effort.
Rich-Garg N; Danve A; Choi D; Vakil-Gilani K; Akkoc N; Azevedo V; Russell A; Sharma A; Cush J; Curtis JR; Deodhar A
Clin Rheumatol; 2021 Mar; 40(3):949-954. PubMed ID: 32797363
[TBL] [Abstract][Full Text] [Related]
38. The value of SPARCC sacroiliac MRI scoring in axial psoriatic arthritis and its association with other disease parameters.
Gezer HH; Duruöz MT
Int J Rheum Dis; 2022 Apr; 25(4):433-439. PubMed ID: 35080124
[TBL] [Abstract][Full Text] [Related]
39. Use of the Bath Ankylosing Spondylitis Disease Activity Index in Patients With Psoriatic Arthritis With and Without Axial Disease.
Reddy SM; Xue K; Husni ME; Scher JU; Stephens-Shields AJ; Goel N; Koplin J; Craig ET; Walsh JA; Ogdie A
J Rheumatol; 2024 Feb; 51(2):139-143. PubMed ID: 38101918
[TBL] [Abstract][Full Text] [Related]
40. Extent of axial damage in psoriatic arthritis and spondyloarthritis: comparative data from the BEPAS and (Be-)GIANT multicentre cohorts.
de Hooge M; Ishchenko A; De Craemer AS; Steinfeld S; Nzeusseu A; Elewaut D; Lories R; de Vlam K; Van den Bosch F
RMD Open; 2023 May; 9(2):. PubMed ID: 37137541
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
